U.S. Pharmaceutical Cdmo Market Size & Outlook, 2025-2033

Name: U.S. Pharmaceutical Cdmo Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The pharmaceutical cdmo market in the United States is expected to reach a projected revenue of US$ 65,315.7 million by 2033. A compound annual growth rate of 6.7% is expected of the United States pharmaceutical cdmo market from 2025 to 2033.

U.S. pharmaceutical cdmo product outlook (Revenue, USD million, 2021-2033)
- API
  - Synthetic
    - Solid
    - Liquid
  - Biotech
- Drug Product
  - Oral Solid Dose
  - Semi-solid Dose
  - Liquid Dose
  - Others
U.S. pharmaceutical cdmo work flow outlook (Revenue, USD million, 2021-2033)
- Clinical
- Commercial
U.S. pharmaceutical cdmo application outlook (Revenue, USD million, 2021-2033)
- Oncology
- Infectious Diseases
- Neurological Disorders
- Cardiovascular Diseases
- Metabolic Disorders
- Autoimmune Diseases
- Respiratory Diseases
- Ophthalmology
- Gastrointestinal Disorders
- Hormonal Disorders
- Hematological Disorders
- Others
U.S. pharmaceutical cdmo service outlook (Revenue, USD million, 2021-2033)
- Contract Development
- Contract Manufacturing
- Packaging
- Quality Control and Assurance
- Others
U.S. pharmaceutical cdmo end use outlook (Revenue, USD million, 2021-2033)
- Pharmaceutical Companies
- Biotechnology Companies
- Others

U.S. Pharmaceutical Cdmo Market Size & Outlook, 2025-2033

Sign up - it's easy, and free!